Article
Local Delivery of Accutox® Synergises With Immune-checkpoint Inhibitors at Disrupting Tumor Growth
2024-02-15
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: The Accum® platform was initially designed to accumulate biomedicines in target cells by inducing endosomal-to-cytosol escape. Interestingly however, the use of unconjugated Accum® was observed to trigger cell death in a variety of cancer cell lines; a property that was further exploited in the development of Accum®-based anti-cancer therapies. Despite the impre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f82c28c0-a6f0-54b6-a020-af755941fafb
- DOI
- 10.21203/rs.3.rs-3950210/v1
